BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35496992)

  • 1. Role of vitamin C in preventing of COVID-19 infection, progression and severity.
    Shahbaz U; Fatima N; Basharat S; Bibi A; Yu X; Hussain MI; Nasrullah M
    AIMS Microbiol; 2022; 8(1):108-124. PubMed ID: 35496992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of high-dose intravenous vitamin C for patients with coronavirus disease 2019: A systematic review and meta-analysis.
    Kwak SG; Choo YJ; Chang MC
    Complement Ther Med; 2022 Mar; 64():102797. PubMed ID: 34953366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Vitamin C on the Multiple Pathophysiological Stages of COVID-19.
    Miranda-Massari JR; Toro AP; Loh D; Rodriguez JR; Borges RM; Marcial-Vega V; Olalde J; Berdiel MJ; Riordan NH; Martinez JM; Gil A; Gonzalez MJ
    Life (Basel); 2021 Dec; 11(12):. PubMed ID: 34947872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low level of Vitamin C and dysregulation of Vitamin C transporter might be involved in the severity of COVID-19 Infection.
    Patterson T; Isales CM; Fulzele S
    Aging Dis; 2021 Feb; 12(1):14-26. PubMed ID: 33532123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Dose Intravenous Ascorbate in Sepsis, a Pro-Oxidant Enhanced Microbicidal Activity and the Effect on Neutrophil Functions.
    Sae-Khow K; Charoensappakit A; Chiewchengchol D; Leelahavanichkul A
    Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C.
    Vollbracht C; Kraft K
    Front Pharmacol; 2022; 13():899198. PubMed ID: 35571085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Variable Nature of Vitamin C-Does It Help When Dealing with Coronavirus?
    Grudlewska-Buda K; Wiktorczyk-Kapischke N; Budzyńska A; Kwiecińska-Piróg J; Przekwas J; Kijewska A; Sabiniarz D; Gospodarek-Komkowska E; Skowron K
    Antioxidants (Basel); 2022 Jun; 11(7):. PubMed ID: 35883738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential metals, vitamins and antioxidant enzyme activities in COVID-19 patients and their potential associations with the disease severity.
    Al-Saleh I; Alrushud N; Alnuwaysir H; Elkhatib R; Shoukri M; Aldayel F; Bakheet R; Almozaini M
    Biometals; 2022 Feb; 35(1):125-145. PubMed ID: 34993712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of high dose vitamin C in management of hospitalised COVID-19 patients: A minireview.
    Juneja D; Gupta A; Kataria S; Singh O
    World J Virol; 2022 Sep; 11(5):300-309. PubMed ID: 36188745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of megadose vitamin C to reverse organ dysfunction in sepsis and COVID-19.
    May CN; Bellomo R; Lankadeva YR
    Br J Pharmacol; 2021 Oct; 178(19):3864-3868. PubMed ID: 34061355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trial.
    Beigmohammadi MT; Bitarafan S; Hoseindokht A; Abdollahi A; Amoozadeh L; Mahmoodi Ali Abadi M; Foroumandi M
    Trials; 2020 Jul; 21(1):614. PubMed ID: 32631405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Emerging Role of Vitamin C as a Treatment for Sepsis.
    Kashiouris MG; L'Heureux M; Cable CA; Fisher BJ; Leichtle SW; Fowler AA
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 31978969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study.
    Zhao B; Liu M; Liu P; Peng Y; Huang J; Li M; Wang Y; Xu L; Sun S; Qi X; Ling Y; Li J; Zhang W; Mao E; Qu J
    Front Pharmacol; 2021; 12():638556. PubMed ID: 33967773
    [No Abstract]   [Full Text] [Related]  

  • 20. The coronavirus disease (COVID-19) - A supportive approach with selected micronutrients.
    Gröber U; Holick MF
    Int J Vitam Nutr Res; 2022 Jan; 92(1):13-34. PubMed ID: 33487035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.